These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30243831)

  • 1. Microglia polarization by mitochondrial metabolism modulation: A therapeutic opportunity in neurodegenerative diseases.
    Di Stadio A; Angelini C
    Mitochondrion; 2019 May; 46():334-336. PubMed ID: 30243831
    [No Abstract]   [Full Text] [Related]  

  • 2. Antioxidant modulation in restoring mitochondrial function in neurodegeneration.
    Pahrudin Arrozi A; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Int J Neurosci; 2017 Mar; 127(3):218-235. PubMed ID: 27074540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological advances in mitochondrial therapy.
    Singh A; Faccenda D; Campanella M
    EBioMedicine; 2021 Mar; 65():103244. PubMed ID: 33647769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoprotective pyridinol antioxidants as potential therapeutic agents for neurodegenerative and mitochondrial diseases.
    Alam MP; Khdour OM; Arce PM; Chen Y; Roy B; Johnson WG; Dey S; Hecht SM
    Bioorg Med Chem; 2014 Sep; 22(17):4935-47. PubMed ID: 25088548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial medicine for neurodegenerative diseases.
    Du H; Yan SS
    Int J Biochem Cell Biol; 2010 May; 42(5):560-72. PubMed ID: 20067840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting antioxidants to mitochondria: a new therapeutic direction.
    Sheu SS; Nauduri D; Anders MW
    Biochim Biophys Acta; 2006 Feb; 1762(2):256-65. PubMed ID: 16352423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can we target oxidative stress in the treatment of neurodegenerative diseases?
    Akasaka H; Ruan KH
    Future Med Chem; 2016 May; 8(8):835-9. PubMed ID: 27173453
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants.
    Cui K; Luo X; Xu K; Ven Murthy MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):771-99. PubMed ID: 15363603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting antioxidants to mitochondria and cardiovascular diseases: the effects of mitoquinone.
    Milagros Rocha M; Victor VM
    Med Sci Monit; 2007 Jul; 13(7):RA132-45. PubMed ID: 17599037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species and mitochondrial diseases.
    Kirkinezos IG; Moraes CT
    Semin Cell Dev Biol; 2001 Dec; 12(6):449-57. PubMed ID: 11735379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamin-related protein-1 as potential therapeutic target in various diseases.
    Singh S; Sharma S
    Inflammopharmacology; 2017 Aug; 25(4):383-392. PubMed ID: 28409390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural antioxidants in hybrids for the treatment of neurodegenerative diseases: a successful strategy?
    Gunesch S; Schramm S; Decker M
    Future Med Chem; 2017 May; 9(8):711-713. PubMed ID: 28485625
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective role of melatonin in mitochondrial dysfunction and related disorders.
    Paradies G; Paradies V; Ruggiero FM; Petrosillo G
    Arch Toxicol; 2015 Jun; 89(6):923-39. PubMed ID: 25690732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin: A Potential Anti-Oxidant Therapeutic Agent for Mitochondrial Dysfunctions and Related Disorders.
    Ganie SA; Dar TA; Bhat AH; Dar KB; Anees S; Zargar MA; Masood A
    Rejuvenation Res; 2016 Feb; 19(1):21-40. PubMed ID: 26087000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial optic neuropathies: our travels from bench to bedside and back again.
    Sadun AA; La Morgia C; Carelli V
    Clin Exp Ophthalmol; 2013; 41(7):702-12. PubMed ID: 23433229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketotherapeutics for neurodegenerative diseases.
    Norwitz NG; Jaramillo JG; Clarke K; Soto A
    Int Rev Neurobiol; 2020; 155():141-168. PubMed ID: 32854853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and neurodegeneration: where are we now?
    Halliwell B
    J Neurochem; 2006 Jun; 97(6):1634-58. PubMed ID: 16805774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
    Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
    Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.